Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance

Author： Yang Lingyun   Li Ningwei   Wang Hongjing   Jia Xibiao   Wang Xue   Luo Juan  

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.28, Iss.2, 2012-08, pp. : 592-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overexpression of the microRNA miR‐433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells

By  

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 745-758

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer

By  

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 591-598

Spandidos Publications

Access to resources Recommend Favorite

NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis

By      

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 188-196

Spandidos Publications

Access to resources Recommend Favorite

Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells

By        

International Journal of Oncology, Vol. 42, Iss. 6, 2013-01 ,pp. : 1875-1882

Spandidos Publications

Access to resources Recommend Favorite

Expression of P-glycoprotein-mediated Drug Resistance in CHO Cells Surviving a Single X-ray Dose of 30 Gy

By McClean S.   Hosking L.K.   Hill B.T.  

International Journal of Radiation Biology, Vol. 63, Iss. 6, 1993-06 ,pp. : 765-773

Informa Healthcare

Access to resources Recommend Favorite